| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |